Concepedia

Tong Ding

TD

Statistics

Publications

5

Citations

166

H-Index

5

Active since

2018

Affiliations

Zymeworks (Canada)(Current)

Center of Hubei Cooperative Innovation for Emissions Trading System

Huazhong Agricultural University

Tong Ding is an author at Zymeworks (Canada) specializing in antibody-drug conjugates, medicinal chemistry, and antibody-drug conjugate therapy.

ORCID

Publications per year

2018–2024

5

Publications

5

Abstract P6-17-13: ZW49, a HER2 targeted biparatopic antibody drug conjugate for the treatment of HER2 expressing cancers

KJ Hamblett, S.D. Barnscher, RH Davies et al. · Cancer Research · 2019 · 49 citations

, , +17

Abstract 3914: ZW49, a HER2-targeted biparatopic antibody-drug conjugate for the treatment of HER2-expressing cancers

Kevin J. Hamblett, Phil W. Hammond, Stuart D. Barnscher et al. · Cancer Research · 2018 · 44 citations

, , +17

Unfolding of an RNA G-quadruplex motif in the negative strand genome of porcine reproductive and respiratory syndrome virus by host and viral helicases to promote viral replication

Puxian Fang, Congbao Xie, Ting Pan et al. · Nucleic Acids Research · 2023 · 31 citations · Full text

, , +17

Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates

Mark E. Petersen, Michael G. Brant, Manuel Lasalle et al. · Molecular Cancer Therapeutics · 2024 · 25 citations · Full text

, , +17

Porcine Epidemic Diarrhea Virus nsp7 Inhibits MDA5 Dephosphorylation to Antagonize Type I Interferon Production

Jian-Song Zhang, Puxian Fang, Jie Ren et al. · Microbiology Spectrum · 2023 · 17 citations · Full text

, , +17

1–5 of 5